09:49:29 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



Evitrade Health Systems Corp
Symbol EVA
Shares Issued 86,208,601
Close 2019-02-19 C$ 0.145
Market Cap C$ 12,500,247
Recent Sedar Documents

Evitrade Health appoints Brown as president

2019-02-21 10:26 ET - News Release

An anonymous director reports

EVITRADE ANNOUNCES THE APPOINTMENT OF CHRIS BROWN AS PRESIDENT

Evitrade Health Systems Corp. has appointed Chris Brown as president of the company.

With over 20 years of practical business experience in both private and public enterprises, Mr. Brown has developed a keen eye for branding and effective corporate sales strategies. Most recently, his business efforts have been focused on developing product lines, along with sales and marketing opportunities within the CBD (cannabidiol) marketplace.

Mr. Brown is also a director and president of Western Agri Supply Solutions Corp. (WASSC), which was acquired by the company in 2018 and continues as one of its wholly owned subsidiaries.

WASSC is an agricultural supply company focused on sourcing and processing industrial hemp. Through utilization of a proprietary industrial-grade extraction system, WASSC is setting up to offer CBD-based health and wellness products based on extracts from industrial hemp. Through initial testing, WASSC has predicted its production capacity to be in excess of 200 kilograms of CBD isolate per month, with an estimated market value currently of $4,000 to $8,000 per kilogram.

Management is extremely pleased to have Mr. Brown join the executive team. His deep connections in the industrial hemp and CBD markets is expected to be an asset for realizing the potential of the company's personalized health system and projected operating plans for revenues.

About Evitrade Health Systems Corp.

Evitrade Health Systems (formerly Auxellence Health Corp.) is a technology company specializing in the health and life sciences sector, looking to deliver effective personalized health solutions with a higher degree of predictability and consistency.

The company is focused on the following areas to help improve health: personalized medical care (including CBD usage monitoring and effects on the cardiovascular system), molecular biology, nutraceutical solutions and genetic tailoring.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.